Table 3. Crude and adjusted Hazard Ratios for differentiated thyroid cancer patients, using the Cox model.
Variables | Crude HRa | 95%CIb | p valuec | Multivariate model using age grouping of the TNM 7th edition | Multivariate model using age grouping of the TNM 8th edition | |||||
---|---|---|---|---|---|---|---|---|---|---|
adjusted HRa | 95%CIb | p valuec | adjusted HRa | 95%CIb | p valuec | |||||
Gender | ||||||||||
Female | 1.00 | Multivariate Cox model stratified by gender | ||||||||
Male | 2.75 | 1.16 – 6.52 | 0.022 | |||||||
Age at diagnosis – TNM 7th edition | ||||||||||
20-44 | 1.00 | 1.00 | - | - | - | |||||
≥ 45 | 8.68 | 2.02 – 37.27 | 0.004 | 9.88 | 1.67 – 58.33 | 0.011 | - | - | - | |
Age at diagnosis – TNM 8th edition | ||||||||||
20-54 | 1.00 | - | - | - | 1.00 | |||||
≥ 55 | 17.60 | 5.18 – 59.76 | < 0.001 | - | - | - | 10.12 | 2.05 – 50.09 | 0.005 | |
Distant metastasis | ||||||||||
No | 1.00 | 1.00 | 1.00 | |||||||
Yes | 28.61 | 12.08 – 67.77 | < 0.001 | 18.87 | 7.38 – 48.29 | < 0.001 | 12.43 | 4.58 – 33.77 | < 0.001 | |
Radioiodine therapy | ||||||||||
No | 1.00 | 1.00 | 1.00 | |||||||
Yes | 0.22 | 0.09 – 0.52 | 0.001 | 0.16 | 0.06 – 0.43 | < 0.001 | 0.19 | 0.07 – 0.51 | 0.001 | |
Lymphadenectomy | ||||||||||
No | 1.00 | 1.00 | 1.00 | |||||||
Yes | 2.57 | 1.10 – 6.02 | 0.035 | 6.36 | 2.26 – 17.91 | 0.001 | 5.06 | 1.82 – 14.05 | 0.002 | |
Tumor size | ||||||||||
< 4.0 cm | 1.00 | - | - | - | - | - | - | |||
≥ 4.0 cm | 5.18 | 2.20 – 12.2 | < 0.001 | - | - | - | - | - | - | |
Microcarcinoma | ||||||||||
Yes | 1.00 | - | - | - | - | - | - | |||
No | 2.71 | 0.80 – 9.20 | 0.110 | - | - | - | - | - | - | |
Radiotherapy | ||||||||||
No | 1.00 | |||||||||
Yes | 8.96 | 3.47 – 23.13 | < 0.001 |
Hazard Ratio;
CI= confidence interval;
Wald’s test p value, being in bold when p < 0.05.
Histological type and regional lymph nodes metastasis variables presented p > 0.20 in univariate Cox model.